Cervical Cancer Screening Guideline Adherence Before and After Guideline Changes in Pennsylvania Medicaid

2017 ◽  
Vol 129 (1) ◽  
pp. 66-75 ◽  
Author(s):  
Natasha Parekh ◽  
Julie M. Donohue ◽  
Aiju Men ◽  
Jennifer Corbelli ◽  
Marian Jarlenski
2021 ◽  
Vol 60 (5) ◽  
pp. 666-673
Author(s):  
Anna-Barbara Moscicki ◽  
Charlene Chang ◽  
Sitaram Vangala ◽  
Xinkai Zhou ◽  
David A. Elashoff ◽  
...  

2016 ◽  
Vol 44 (1) ◽  
pp. 22-39 ◽  
Author(s):  
Elisia L. Cohen ◽  
Allison M. Scott ◽  
Rachael Record ◽  
Sara Shaunfield ◽  
M. Grace Jones ◽  
...  

2020 ◽  
Vol 49 ◽  
pp. 77
Author(s):  
I. Anikpo ◽  
M.J. Cvitanovich ◽  
K. Craten ◽  
A. Manza-A. Agovi ◽  
R.P. Ojha

2018 ◽  
Author(s):  
Roxane Camail ◽  
Bruno Kenfack ◽  
Phuong Lien Tran ◽  
Manuela Viviano ◽  
Pierre-Marie Tebeu ◽  
...  

BACKGROUND Women undergoing pelvic examination for cervical cancer screening can experience periprocedural anxiety. OBJECTIVE The aim of this study was to assess the anxiety level experienced by women undergoing a visual inspection with acetic acid and Lugol iodine (VIA and VILI) examination, with or without watching the procedure on a digital screen. METHODS This prospective randomized study took place in the district of Dschang, Cameroon. A previous cervical cancer screening campaign tested women aged between 30 and 49 years for human papillomavirus (HPV). HPV-positive women were invited for the 12-month follow-up control visit, including a VIA/VILI examination. During that visit, we recruited women to participate in this study. Before the examination, participants were randomized in a 1:1 ratio to a control group (CG) and an intervention group (IG). Women in both groups underwent a pelvic examination and were verbally informed about the steps undertaken during the gynecological examination. The IG could also watch it live on a tablet screen. Women’s anxiety was assessed before and immediately after the examination, using the Spielberger State-Trait Anxiety Inventory (STAI). A paired t test was used to compare the mean STAI score for each question before and after VIA/VILI while a nonpaired, 2-sided t test was used to compare the mean differences of the STAI score between the 2 study groups. RESULTS A total of 122 women were randomized in the study; 4 of them were excluded as they did not undergo the pelvic examination, did not answer to the second STAI questionnaire because of personal reasons, or the cervix could not be properly visualized. Thus, the final sample size consisted of 118 patients of whom 58 women were assigned to the CG and 60 to the IG. The mean age was 39.1 (SD 5.2) years. Before the examination, the mean (SD) STAI score was 33.6 (SD 10.9) in the CG and 36.4 (SD 11.8) in the IG (P=.17). The STAI score after pelvic examination was significantly reduced for both groups (CG: 29.3 [SD 11.2]; IG: 28.5 [SD 12.0]). Overall, the difference of the STAI scores before and after the pelvic examination was lower in the CG (4.2 [SD 9.0]) than in the IG (7.9 [SD 14.3]), although the difference was not significant (P=.10). However, the women’s emotional state, such as I feel secure and I feel strained, was improved in the IG as compared with the CG (CG: P=.01; IG: P=.007). CONCLUSIONS Watching the VIA/VILI procedure in real time improved the women’s emotional state but did not reduce the periprocedural anxiety measured by the STAI score. Furthermore, larger studies should assess women’s satisfaction with watching their pelvic examination in real time to determine whether this tool could be included in VIA/VILI routine practice. CLINICALTRIAL ClinicalTrials.gov NCT02945111; http://clinicaltrials.gov/ct2/show/NCT02945111


Author(s):  
Richard Chandra ◽  
Syahrul Rauf ◽  
Umar Malinta

Objective: To determine the level of acceptance of self Human Papilloma Virus (HPV) examination and to compare the level of sensitivity and specificity of self HPV examination with Fluid Based Cytology on precancerous cervical lesion and cervical cancer. Methods: The analytical method used in this research was cross sectional with purposive sampling. This study is conducted at Wahidin Sudirohusodo Hospital and its affiliation from October 2014 to May 2015 with 101 subjects. The data measurement used self HPV examination tool and fluid based cytology kit. The data collected through questionnaires before and after the examination. The laboratory examination was carried out using the way of HPV Genotyping primary system (MY09/11) method Wl LTS-06, which is able to detect 35 types of HPV viruses. Results: A total of 101 subjects were involved in this study. The subjects were divided into two groups: the abnormal and normal group (n - 50/51). The acceptance level of self HPV examination was 62.37% (n = 63/101). Majority of subjects (88.21%) were ready to repeat the same examination in the future. The level of sensitivity and specificity for self HPV were (56% (95%CI (41.25 - 70.01%)) vs 98% (95%CI (89.55 - 99.95%)), p=<0.000001, while the level of sensitivity and specificity for fluid based cytology were (40% (95%CI (26.41 - 54.82%)) vs 98% (95%CI (89.35 - 99.95%)), p=0.000002. Conclusion: HPV self-testing is very potential to be used as an alternative method for cervical cancer screening. [Indones J Obstet Gynecol 2017; 5-2: 114-119] Keywords: cervical cancer, cervical cancer screening, human papilloma virus, sensitivity, specificity


Medical Care ◽  
2018 ◽  
Vol 56 (7) ◽  
pp. 561-568 ◽  
Author(s):  
Natasha Parekh ◽  
Julie M. Donohue ◽  
Jennifer Corbelli ◽  
Aiju Men ◽  
David Kelley ◽  
...  

2019 ◽  
Vol 23 (4) ◽  
pp. 320-328 ◽  
Author(s):  
Rhonda Lynn Goodman

Indigenous Maya women in Guatemala have little or no access to cervical cancer screening or follow-up care. Healthcare groups initiated a program to address this situation. This study collected the women's stories before and after screening. Screening was conducted by a licensed Guatemalan medical doctor. The participants had never experienced cervical cancer screening. They were given an opportunity to tell how they felt about the screening. The stories provide an opportunity to learn of the experience of cervical cancer screening as perceived by the indigenous Maya women and could assist to develop culturally appropriate approaches to this population.


PLoS ONE ◽  
2020 ◽  
Vol 15 (3) ◽  
pp. e0229924
Author(s):  
Yasuhiro Miki ◽  
Toru Tase ◽  
Hideki Tokunaga ◽  
Nobuo Yaegashi ◽  
Kiyoshi Ito

Sign in / Sign up

Export Citation Format

Share Document